Unique site- and time-specific patterns of recurrence following resection of colorectal carcinoma hepatic metastases in patients staged by FDG-PET

Journal of Hepato-Biliary-Pancreatic Surgery

Volumn 15, Issue 5, 2008, Pages 483-487

  Finkelstein, Steven E ^a   Fernandez, Felix G ^a   Dehdashti, Farrokh ^a,b   Siegel, Barry A ^a,b   Hawkins, William G ^a,b   Linehan, David C ^a,b   Strasberg, Steven M ^a,b  

^a BARNES JEWISH HOSPITAL   (United States)

^b USA   (United States)

Author keywords

Colorectal cancer; Liver metastases; Positron emission tomography; Recurrence; Surgery

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER RECURRENCE; CANCER STAGING; COLORECTAL CARCINOMA; COLORECTAL SURGERY; CONTROLLED STUDY; FEMALE; GASTROINTESTINAL TRACT SCINTISCANNING; GROWTH ACCELERATION; HUMAN; INTERMETHOD COMPARISON; LIVER METASTASIS; LIVER RESECTION; LIVER SCINTISCANNING; MAJOR CLINICAL STUDY; MALE; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE EVALUATION; RECURRENCE RISK;

ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; POSITRON-EMISSION TOMOGRAPHY; PREOPERATIVE CARE; RADIOPHARMACEUTICALS; TIME FACTORS; YOUNG ADULT;

EID: 53549120911     PISSN: 09441166     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00534-007-1237-2     Document Type: Article

References (40)

1. Fernandez FG, Drebin JA, Linehan DC, Dehdashti F, Siegel B, Strasberg SM. Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose (FDG-PET). Ann Surg 2004;240:438-447.
2. Adson MA, van Heerden JA, Adson MH, et al. Resection of hepatic metastases from colorectal cancer. Arch Surg 1984;119:647-651.
3. Anonymous. Resection of the liver for colorectal carcinoma metastases: A multi-institutional study of indications for resection. Registry of Hepatic Metastases. Surgery 1988;103:278-288.
4. Bramhall SR, Gur U, Coldham C, et al. Liver resection for colorectal metastases. Ann R Coll Surg Engl 2003;85:334-339.
5. Doci R, Gennari L, Bignami P, et al. One hundred patients with hepatic metastases from colorectal cancer treated by resection: Analysis of prognostic determinants. Br J Surg 1991;78:797-801.
6. Ekberg H, Tranberg KG, Andersson R, et al. Determinants of survival in liver resection for colorectal secondaries. Br J Surg 1986;73:727-731.
7. Gayowski TJ, Iwatsuki S, Madariaga JR, et al. Experience in hepatic resection for metastatic colorectal cancer: Analysis of clinical and pathologic risk factors [see comment]. Surgery 1994;116:703-710.
8. Gazzaniga GM, Cogolo LA, Ciferri E, Pestarino C. Liver surgery for metastases: Clinical results. J Surg Oncol (Suppl) 1991;2:59-62.
9. Jamison RL, Donohue JH, Nagorney DM, et al. Hepatic resection for metastatic colorectal cancer results in cure for some patients. Arch Surg 1997;132:505-510.
10. Jenkins LT, Millikan KW, Bines SD, et al. Hepatic resection for metastatic colorectal cancer. Am Surg 1997;63:605-610.
11. Kato T, Yasui K, Hirai T, et al. Therapeutic results for hepatic metastasis of colorectal cancer with special reference to effective ness of hepatectomy: Analysis of prognostic factors for 763 cases recorded at 18 institutions. Dis Colon Rectum 2003;46(10 Suppl):S22-31.
12. Liu CL, Fan ST, Lo CM, et al. Hepatic resection for colorectal liver metastases: Prospective study. Hong Kong Med J 2002;8:329-333.
13. Nordlinger B, Guiguet M, Vaillant JC, et al. Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Ass Franc Chir Cancer 1996;77:1254-1262.
14. Rees M, Plant G, Bygrave S. Late results justify resection for multiple hepatic metastases from colorectal cancer. Br J Surg 1997;84:1136-1140.
15. Scheele J, Stang R, Altendorf-Hofmann A, Paul M. Resection of colorectal liver metastases. World J Surg 1995;19:59-71.
16. Schlag P, Hohenberger P, Herfarth C. Resection of liver metastases in colorectal cancer-competitive analysis of treatment results in synchronous versus metachronous metastases. Eur J Surg Oncol 1990;16:360-365.
17. Stehlin JS Jr, de Ipolyi PD, Greeff PJ, et al. Treatment of cancer of the liver. Twenty years' experience with infusion and resection in 414 patients. Ann Surg 1988;208:23-35.
18. Yamaguchi A, Kurosaka Y, Kanno M, et al. Analysis of hepatic recurrence of colorectal cancer after resection of hepatic metastases. Int Surg 1993;78:16-19.
19. Fong Y, Fortner J, Sun RL, et al. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 1999;230:309-318; discussion 318-21.
20. Yang Y, Fleshman J, Strasberg SM. Detection and management of extrahepatic colorectal cancer in patients with resectable liver metastases. J Gastrointest Surg 2006;11:929-944.
21. Arulampalam TH, Francis DL, Visvikis D, et al. FDG-PET for the pre-operative evaluation of colorectal liver metastases. Eur J Surg Oncol 2004;30:286-291.
22. Strasberg SM, Dehdashti F, Siegel BA, et al. Survival of patients evaluated by FDG-PET before hepatic resection for metastatic colorectal carcinoma: A prospective database study. Ann Surg 2001;233:293-299.
23. Rosa F, Meimarakis G, Stahl A, et al. Colorectal cancer patients before resection of hepatic metastases. Impact of (18) F-FDG PET on detecting extrahepatic disease. Nucl Med 2004;43:135-140.
24. Lai DT, Fulham M, Stephen MS, et al. The role of whole-body positron emission tomography with [18F] fluorodeoxyglucose in identifying operable colorectal cancer metastases to the liver. Arch Surg 1996;131:703-707.
25. Ruers TJ, Langenhoff BS, Neeleman N, et al. Value of positron emission tomography with [F-18] fluorodeoxyglucose in patients with colorectal liver metastases: A prospective study. J Clin Oncol 2002;20:388-395.
26. Schussler-Fiorenza CM, Mahvi DM, Niederhuber J, et al. Clinical risk score correlates with yield of PET scan in patients with colorectal hepatic metastases. J Gastrointest Surg 2004;8:150-157.
27. Truant S, Huglo D, Hebbar M, et al. Prospective evaluation of the impact of [18F] fluoro-2-deoxy-D-glucose positron emission tomography of resectable colorectal liver metastases. Br J Surg 2005;92:362-369.
28. Vitola JV, Delbeke D, Sandler MP, et al. Positron emission tomography to stage suspected metastatic colorectal carcinoma to the liver. Am J Surg 1996;171:21-26.
29. Zhuang H, Sinha P, Pourdehnad M, et al. The role of positron emission tomography with fluorine-18-deoxyglucose in identifying colorectal cancer metastases to liver. Nucl Med Commun 2000;21:793-798.
30. Fong Y, Saldinger PF, Akhurst T, et al. Utility of 18F-FDG positron emission tomography scanning on selection of patients for resection of hepatic colorectal metastases. Am J Surg 1999;178:282-287.
31. Altendorf-Hofmann A, Scheele J. A critical review of the major indicators of prognosis after resection of hepatic metastases from colorectal carcinoma. Surg Oncol Clin N Am 2003;12:165-192.
32. Terminology Committee of the International Hepato-Pancreato-Biliary Association. Terminology of liver anatomy and resections. HPB (Oxford) 2000;2:233-239.
33. Kinkel K, Lu Y, Both M, et al. Detection of hepatic metastases from cancers of the gastrointestinal tract by using noninvasive imaging methods (US, CT, MR imaging, PET): A meta-analysis. Radiology 2002;224:748-756.
34. Huebner RH, Park KC, Shepherd JE, et al. A meta-analysis of the literature for whole-body FDG PET detection of recurrent colorectal cancer. J Nucl Med 1997;41:1177-1189.
35. Bipat S, van Leeuwen MS, Comans EFI, et al. Colorectal liver metastases: CT, MR imaging, and PET for diagnosis-meta-analysis. Radiology 2005;237:123-131.
36. Panis Y, Ribeiro J, Chretien Y, Nordlinger B. Dormant liver metastases: an experimental study. Br J Surg 1992;79:221-223.
37. Drixler TA, Borel Rinkes IH, Ritchie ED, et al. Continuous administration of angiostatin inhibits accelerated growth of colorectal liver metastases after partial hepatectomy. Cancer Res 2000;60:1761-1765.
38. van der Bilt JD, Kranenburg O, Nijkamp MW, et al. Ischemia/reperfusion accelerates the outgrowth of hepatic micrometastases in a highly standardized murine model. Hepatology 2005;42:165-175.
39. Elias D, De Baere T, Roche A, Ducreux M, Leclere J, Lasser P. During liver regeneration following right portal embolization the growth rate of liver metastases is more rapid than that of the liver parenchyma. Br J Surg 1999;86:784-788.
40. Yoon SS, Kim SH, Gonen M, et al. Profile of plasma angiogenic factors before and after hepatectomy for colorectal cancer liver metastases. Ann Surg Oncol 2006;13:353-362.